GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 355 filers reported holding GUARDANT HEALTH INC in Q1 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62 | -8.8% | 2,088 | +9.8% | 0.00% | – |
| Q2 2023 | $68 | +74.4% | 1,901 | +15.4% | 0.00% | – |
| Q1 2023 | $39 | -98.3% | 1,647 | -98.1% | 0.00% | -100.0% |
| Q4 2022 | $2,316 | -99.9% | 85,165 | +18.0% | 0.01% | -50.0% |
| Q3 2022 | $3,886,000 | -2.7% | 72,192 | -27.1% | 0.01% | +9.1% |
| Q2 2022 | $3,995,000 | -38.0% | 99,043 | +1.8% | 0.01% | -15.4% |
| Q1 2022 | $6,445,000 | -49.1% | 97,300 | -23.1% | 0.01% | -55.2% |
| Q4 2021 | $12,654,000 | -23.1% | 126,517 | -3.9% | 0.03% | -29.3% |
| Q3 2021 | $16,463,000 | -15.4% | 131,690 | -15.9% | 0.04% | -10.9% |
| Q2 2021 | $19,452,000 | -14.1% | 156,632 | +5.6% | 0.05% | -25.8% |
| Q1 2021 | $22,638,000 | +20.6% | 148,301 | +1.8% | 0.06% | +12.7% |
| Q4 2020 | $18,773,000 | -39.1% | 145,665 | -47.2% | 0.06% | +12.2% |
| Q3 2020 | $30,822,000 | +39.2% | 275,746 | +1.0% | 0.05% | +25.6% |
| Q2 2020 | $22,144,000 | +251.8% | 272,948 | +201.8% | 0.04% | +21.9% |
| Q1 2020 | $6,295,000 | -18.3% | 90,443 | -8.3% | 0.03% | +6.7% |
| Q4 2019 | $7,707,000 | +38.0% | 98,627 | +12.8% | 0.03% | +15.4% |
| Q3 2019 | $5,583,000 | – | 87,471 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |